Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)

PHASE3TerminatedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

January 16, 2020

Primary Completion Date

May 15, 2025

Study Completion Date

May 15, 2025

Conditions
Multiple Sclerosis
Interventions
DRUG

RPC-1063

Oral capsule

Trial Locations (61)

10016

Local Institution - 130, New York

10021

Local Institution - 121, New York

11772

Local Institution - 146, Patchogue

14202

Local Institution - 137, Buffalo

14226

Dent Neurologic Institute, Amherst

15213

University of Pittsburgh Medical Center Magee Womens Hospital, Pittsburgh

19107

Local Institution - 159, Philadelphia

19140

Local Institution - 169, Philadelphia

20007

Local Institution - 109, Washington D.C.

23502

Local Institution - 103, Norfolk

25701

Local Institution - 156, Huntington

26506

Local Institution - 150, Morgantown

27405

Local Institution - 106, Greensboro

27514

Local Institution - 131, Chapel Hill

27607

Raleigh Neurology Associates PA, Raleigh

28117

Local Institution - 170, Mooresville

31406

Local Institution - 114, Savannah

33428

Local Institution - 140, Boca Raton

35058

Local Institution - 136, Cullman

35209

Local Institution - 123, Birmingham

36617

Local Institution - 153, Mobile

37064

Local Institution - 125, Franklin

37922

Local Institution - 119, Knoxville

44106

Local Institution - 171, Cleveland

45219

Local Institution - 174, Cincinnati

45417

Local Institution - 142, Dayton

48201

Local Institution - 152, Detroit

48202

Local Institution - 112, Detroit

50010

Local Institution - 126, Ames

53226

Local Institution - 147, Milwaukee

53792

Local Institution - 167, Madison

59405

Advanced Neurology Specialists, Great Falls

60062

Local Institution - 108, Northbrook

60169

Northwest Neurology, Ltd, Hoffman Estates

63110

Local Institution - 122, St Louis

63131

Local Institution - 143, St Louis

66160

Local Institution - 173, Kansas City

71301

Local Institution - 133, Alexandria

73104

Local Institution - 157, Oklahoma City

75246

Local Institution - 139, Dallas

78259

Local Institution - 101, San Antonio

78681

Local Institution - 113, Round Rock

80045

Local Institution - 107, Aurora

80528

Local Institution - 144, Fort Collins

80907

Local Institution - 102, Colorado Springs

85018

Local Institution - 162, Phoenix

91105

Local Institution - 128, Pasadena

95817

Local Institution - 164, Sacramento

98034

Local Institution - 141, Kirkland

98101

Local Institution - 168, Seattle

98405

Local Institution - 124, Tacoma

99202

Local Institution - 172, Spokane

32960-4818

Local Institution - 158, Vero Beach

46825-1603

Local Institution - 148, Fort Wayne

07666

Local Institution - 149, Teaneck

11733-3528

Local Institution - 160, East Setauket

N6G 2V4

Local Institution - 203, London

K1H 8L6

Local Institution - 204, Ottawa

H2X 0A9

Local Institution - 206, Montreal

B3R 1V9

Local Institution - 207, Halifax

00968

Local Institution - 166, Guaynabo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY

NCT04140305 - Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) | Biotech Hunter | Biotech Hunter